1. 1) Selkoe, D. J. Alzheimer’s Disease: Genes, Proteins, and Therapy. Physiol. Rev. 81, 741-766 (2001).
2. 2) Bosman, G. J.; Bartholomeus I. G.; de Man A. J.; van Kalmthout P. J.; de Grip W. J. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer’s disease. Neurobiol. Aging 12, 13-18 (1991).
3. 3) Goodall, H. B.; Reid, A. H.; Findlay, D. J.; Hind, C.; Kay, J.; Coghill, G. Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis. Markers 12, 23-41 (1994).
4. 4) Miyazawa, T.; Suzuki, T.; Yasuda, K; Fujimoto, K.; Meguro, K.; Sasaki, H. Accumulation of phospholipid hydroperoxides in red blood cell membranes in Alzheimer disease. In Oxygen Radicals (Yagi, K.; Kondo, M.; Niki, E.; Yoshikawa, T. eds.), Elsevier Sci. Publ., Amsterdam, pp. 327-330 (1992).
5. 5) Solerte, S. B.; Ceresini, G.; Ferrari, E.; Fioravanti, M. Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system. Neurobiol. Aging 21, 271-281 (2000).